A phase II study of preradiotherapy chemotherapy followed by hyperfractionated radiotherapy for newly diagnosed high-risk medulloblastoma/primitive neuroectodermal tumor: a report from the Children's Oncology Group (CCG 9931)
Document Type
Journal Article
Publication Date
2009
Journal
International Journal of Radiation Oncology Biology Physics
Volume
74
Issue
4
Inclusive Pages
1006-1011
APA Citation
Allen, J., Donahue, B., Mehta, M., Miller, D., & Rorke, L. (2009). A phase II study of preradiotherapy chemotherapy followed by hyperfractionated radiotherapy for newly diagnosed high-risk medulloblastoma/primitive neuroectodermal tumor: a report from the Children's Oncology Group (CCG 9931). International Journal of Radiation Oncology Biology Physics, 74 (4). Retrieved from https://hsrc.himmelfarb.gwu.edu/smhs_rad_facpubs/525
COinS